The news is that they've 'accelerated' the timeline by pushing back commercialisation by a further 12 months.
That's assuming that the 18 month clinical phase which now appears to be 6 months doesn't also need adjustments further down the line.
No news would have been good news in this case I'm afraid.
Back in the bottom drawer for this one.
The news is that they've 'accelerated' the timeline by pushing...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.67M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 59.0¢ | 57.0¢ | $43.21K | 74.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11657 | 56.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.59pm 21/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |